Sutton Wealth Advisors Inc. Neurocrine Biosciences Inc Transaction History

Sutton Wealth Advisors Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 07, 2023	SELL	$94.11 - $123.02 $1,317 - $1,722	-14 Closed	0 $0
Q2 2022 Nov 07, 2023	SELL	$75.79 - $100.07 $11,292 - $14,910	-149 Reduced 91.41%	14 $1.37 Million
Q1 2022 Nov 07, 2023	BUY	$72.45 - $94.81 $217 - $284	3 Added 1.88%	163 $15.3 Million
Q4 2021 Nov 07, 2023	BUY	$79.65 - $106.22 $876 - $1,168	11 Added 7.38%	160 $13.6 Million
Q4 2017 Nov 06, 2023	BUY	$58.53 - $77.59 $8,720 - $11,560	149	149 $11.6 Million

649

97.1M

749K

553K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.